Translation of hemodynamic stress to sterile inflammation in the heart

Trends in Endocrinology and Metabolism

Volumn 24, Issue 11, 2013, Pages 546-553

  Nakayama, Hiroyuki ^a   Otsu, Kinya ^b  

^a OSAKA UNIVERSITY   (Japan)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autophagy; DNase II; Heart failure; Inflammation; Mitochondrion; TLR9

Indexed keywords

CRYOPYRIN; DEOXYRIBONUCLEASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

AUTOIMMUNE DISEASE; AUTOPHAGOSOME; AUTOPHAGY; CARDIOVASCULAR DISEASE; CARDITIS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DISEASE COURSE; HEART FAILURE; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEMODYNAMIC STRESS; HUMAN; INNATE IMMUNITY; MACROAUTOPHAGY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AUTOPHAGY; DNASE II; HEART FAILURE; INFLAMMATION; MITOCHONDRION; TLR9;

DNA, MITOCHONDRIAL; HEART; HEART FAILURE; HEMODYNAMICS; HUMANS; INFLAMMASOMES; INFLAMMATION;

EID: 84886234690     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.06.004     Document Type: Review

References (90)

1. Qaseem A., et al. Management of stable ischemic heart disease: summary of a clinical practice guideline from the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons. Ann. Intern. Med. 2012, 157:735-743.
2. Mensah G.A., Brown D.W. An overview of cardiovascular disease burden in the United States. Health Aff. (Millwood) 2007, 26:38-48.
3. Hobbs R.E. Guidelines for the diagnosis and management of heart failure. Am. J. Ther. 2004, 11:467-472.
4. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
5. Coggins M., Rosenzweig A. The fire within: cardiac inflammatory signaling in health and disease. Circ. Res. 2012, 110:116-125.
6. Marchant D.J., et al. Inflammation in myocardial diseases. Circ. Res. 2012, 110:126-144.
7. Bozkurt B., et al. Biomarkers of inflammation in heart failure. Heart Fail. Rev. 2010, 15:331-341.
8. Maekawa Y., et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J. Am. Coll. Cardiol. 2002, 39:241-246.
9. Mann D.L., et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004, 109:1594-1602.
10. Chung E.S., et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003, 107:3133-3140.
11. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 2002, 91:988-998.
12. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
13. Nakahira K., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
14. Oka T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485:251-255.
15. Shimada K., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
16. Brookes P.S., et al. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004, 287:C817-C833.
17. Baines C.P., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
18. Nakagawa T., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
19. Schaper J., et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991, 83:504-514.
20. Ausma J., et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol. Cell. Biochem. 1998, 186:159-168.
21. Jones M., et al. Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstruction. Circulation 1975, 51:39-67.
22. Chen L., et al. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 2009, 84:91-99.
23. Bugger H., et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc. Res. 2010, 85:376-384.
24. 2+ signaling. Int. J. Biochem. Cell Biol. 2009, 41:1957-1971.
25. Mizushima N. Autophagy: process and function. Genes Dev. 2007, 21:2861-2873.
26. Ding W.X., Yin X.M. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol. Chem. 2012, 393:547-564.
27. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
28. Ravikumar B., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
29. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
30. Hamacher-Brady A., et al. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 2006, 281:29776-29787.
31. Matsui Y., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 2007, 100:914-922.
32. Miyata S., et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am. J. Pathol. 2006, 168:386-397.
33. Kassiotis C., et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation 2009, 120:S191-S197.
34. Shimomura H., et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn. Circ. J. 2001, 65:965-998.
35. Nakai A., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624.
36. Akira S., et al. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
37. Beutler B., et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 2006, 24:353-389.
38. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
39. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
40. Oyama J., et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004, 109:784-789.
41. Shishido T., et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003, 108:2905-2910.
42. Feng Y., et al. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1311-H1318.
43. Riad A., et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 2008, 180:6954-6961.
44. Shimamoto A., et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006, 114:1270-1274.
45. Frantz S., et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 1999, 104:271-280.
46. Birks E.J., et al. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J. Heart Lung Transplant. 2004, 23:228-235.
47. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
48. Rodriguez-Martinez S., et al. TLRs and NODs mRNA expression pattern in healthy mouse eye. Br. J. Ophthalmol. 2005, 89:904-910.
49. Boyd J.H., et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc. Res. 2006, 72:384-393.
50. Knuefermann P., et al. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc. Res. 2008, 78:26-35.
51. Riad A., et al. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H2024-H2031.
52. Pagni P.P., et al. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis. Autoimmunity 2010, 43:275-287.
53. Lotze M.T., et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev. 2007, 220:60-81.
54. Napirei M., et al. Features of systemic lupus erythematosus in DNase1-deficient mice. Nat. Genet. 2000, 25:177-181.
55. Morita M., et al. Gene-targeted mice lacking the Trex1 (DNase III) 3'→5' DNA exonuclease develop inflammatory myocarditis. Mol. Cell. Biol. 2004, 24:6719-6727.
56. Evans C.J., Aguilera R.J. DNase II: genes, enzymes and function. Gene 2003, 322:1-15.
57. Baker K.P., et al. Molecular cloning and characterization of human and murine DNase II. Gene 1998, 215:281-289.
58. Harosh I., et al. Mechanism of action of deoxyribonuclease II from human lymphoblasts. Eur. J. Biochem. 1991, 202:479-484.
59. Lyon C.J., Aguilera R.J. Purification and characterization of the immunoglobulin switch sequence-specific endonuclease (Endo-SR) from bovine spleen. Mol. Immunol. 1997, 34:209-219.
60. Kawane K., et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 2001, 292:1546-1549.
61. Kawane K., et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 2003, 4:138-144.
62. Yoshida H., et al. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 2005, 6:49-56.
63. Kawane K., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006, 443:998-1002.
64. Pollack Y., et al. Methylation pattern of mouse mitochondrial DNA. Nucleic Acids Res. 1984, 12:4811-4824.
65. Cardon L.R., et al. Pervasive CpG suppression in animal mitochondrial genomes. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3799-3803.
66. Gray M.W., et al. Mitochondrial evolution. Science 1999, 283:1476-1481.
67. Zhang Q., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
68. Stunz L.L., et al. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 2002, 32:1212-1222.
69. Srinivasula S.M., et al. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 2002, 277:21119-21122.
70. Martinon F., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
71. Thornberry N.A., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.
72. Shaw P.J., et al. Inflammasomes and autoimmunity. Trends Mol. Med. 2011, 17:57-64.
73. Bruey J.M., et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129:45-56.
74. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
75. Miao E.A., et al. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin. Immunopathol. 2007, 29:275-288.
76. Poeck H., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat. Immunol. 2010, 11:63-69.
77. Mariathasan S., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
78. Kanneganti T.D., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236.
79. Martinon F., et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
80. Craven R.R., et al. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS ONE 2009, 4:e7446.
81. Kanneganti T.D., et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 2006, 281:36560-36568.
82. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009, 459:433-436.
83. Feldmeyer L., et al. Interleukin-1, inflammasomes and the skin. Eur. J. Cell Biol. 2010, 89:638-644.
84. Gross O., et al. The inflammasome: an integrated view. Immunol. Rev. 2011, 243:136-151.
85. Strowig T., et al. Inflammasomes in health and disease. Nature 2012, 481:278-286.
86. Franchi L., et al. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 2012, 13:325-332.
87. Kawaguchi M., et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123:594-604.
88. Mezzaroma E., et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19725-19730.
89. Toldo S., et al. Interleukin-1beta immunoneutralization improves cardiac remodeling after myocardial infarction without interrupting the inflammasome in the mouse. Exp. Physiol. 2013, 98:734-745.
90. Bracey N.A., et al. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1beta. Exp. Physiol. 2013, 98:462-472.